Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 420

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 420
---
05 million,
before deducting agent fees and expenses. Additionally, we issued warrants to purchase 6,456 of our Depositary Shares in connection with
the offering to Ladenburg, as agent, and certain designees of Ladenburg, or Warrant Agent Warrants.

On July 22, 2024, we completed the Offerings with the Investors, pursuant to which we sold in the Registered Direct Offering an aggregate of (i) 202,032 Depositary Shares and (ii) 11,157 July 2024 Pre-Funded Warrants, at a price per Depositary Share of $0.94, and a price per July 2024 Pre-Funded Warrant of $23.4975, and in the concurrent July 2024 Private Placement, we issued and sold to the Investors (x) Series J Warrants exercisable for 213,188 Depositary Shares, and (y) Series K Warrants to purchase an aggregate of 213,188 Depositary Shares. The warrants are immediately exercisable at an exercise price of $25.00 per Depositary Share, subject to adjustments for certain dilutive equity issuances. The aggregate gross proceeds to the Company were approximately $5.0 million. Additionally, we issued July 2024 Placement Agent Warrants to purchase 8,525 of our Depositary Shares in connection with the offering to Ladenburg and certain designees of Ladenburg.

| Item  8. | Exhibits and Financial Statement Schedules |

| (a) | The Exhibit Index is incorporated herein by reference. |

See the Exhibit Index attached
to this registration statement, which is incorporated herein by reference.

| (b) | Financial Statement Schedules. |

Schedules not listed above
have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or
the notes thereto.

| Item 9. | Undertakings |

The undersigned Registrant hereby undertakes:

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this 
 registration statement:                                                                                |

| (i) | to include any prospectus required by section 10(a)(3) of the Securities Act; |

| (ii) | to reflect in the prospectus any facts or events arising after the effective date of the registration                                       
 statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change     
 in the information set